HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Interpretive Summary Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Marques, S. Articles by Thompson, G. Search for Related Content PubMed PubMed Citation Articles by Marques, S. Articles by Thompson, G.

Short Communication: In Vitro Antimicrobial Susceptibility of Prototheca wickerhamii and Prototheca zopfii Isolated from Bovine Mastitis

S. Marques^*,,1, E. Silva^*,, J. Carvalheira^*, and G. Thompson^*,

^* Instituto de Ciências Biomédicas de Abel Salazar (ICBAS),
Unidade Multidisciplinar de Investigação Biomédica (UMIB), and
Centro de Investigação em Biodiversidade e Recursos Genéticos (CIBIO), Universidade do Porto, Porto, Portugal

¹ Corresponding author: saramarques{at}mail.icav.up.pt

Bovine mastitis caused by Prototheca spp. can assume high significance because of economic losses and the potential risk to public health. Studies on the susceptibility of Prototheca spp. to antimicrobials have demonstrated its high level of resistance. We report the susceptibility of bovine isolates of Prototheca wickerhamii and Prototheca zopfii to amphotericin B and nystatin, 2 antifungal agents commonly used in the control of protothecosis, and discuss the results. After subculture, minimum inhibitory concentrations of both antifungal drugs were determined using macrodilution and agar diffusion methods. The inoculum concentration was standardized by determination of colony-forming units per milliliter. Nystatin showed more efficacy than amphotericin B in inhibiting P. wickerhamii growth. In contrast, growth inhibition of P. zopfii was similar for both antifungal agents. This study demonstrates different in vitro susceptibility patterns of P. wickerhamii and P. zopfii, reinforcing the necessity for more investigation into drugs that can be used with clinical efficacy.

Key Words: bovine mastitis • antimicrobial susceptibility • Prototheca

This article has been cited by other articles:

				A. M. Tortorano, A. Prigitano, G. Dho, R. Piccinini, V. Dapra, and M. A. Viviani In vitro activity of conventional antifungal drugs and natural essences against the yeast-like alga Prototheca J. Antimicrob. Chemother., June 1, 2008; 61(6): 1312 - 1314. [Abstract] [Full Text] [PDF]

				S. Marques, E. Silva, C. Kraft, J. Carvalheira, A. Videira, V. A. R. Huss, and G. Thompson Bovine Mastitis Associated with Prototheca blaschkeae J. Clin. Microbiol., June 1, 2008; 46(6): 1941 - 1945. [Abstract] [Full Text] [PDF]